US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 71.740
  • +0.030+0.04%
Trading Apr 30 11:21 ET
222.42BMarket Cap28.87P/E (TTM)

About AstraZeneca Company

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Company Profile

SymbolAZN
Company NameAstraZeneca
Listing DateMay 12, 1993
Founded1992
CEOMr. Pascal Soriot
MarketNASDAQ
Employees94300
Securities TypeDR
ADS Ratio1.0 : 0.5
Fiscal Year Ends12-31
AddressCambridge Biomedical Campus,1 Francis Crick Avenue
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB2 0AA
Phone44-20-3749-5000

Company Executives

  • Name
  • Position
  • Salary
  • Pascal Soriot
  • Executive Director,Chief Executive Officer
  • 14.73M
  • Dr. Aradhana Sarin
  • Executive Director,Chief Financial Officer
  • 6.75M
  • Michel Demare
  • Non-Executive Director,Chairman
  • 800.00K
  • Rene Haas
  • Non-Executive Director
  • --
  • Birgit M. Conix
  • Non-Executive Director
  • --
  • Professor Tony Mok
  • Non-Executive Director
  • 135.00K
  • Professor Nazneen Rahman
  • Non-Executive Director
  • 200.00K
  • Sherilyn S. McCoy
  • Non-Executive Director
  • 205.00K
  • Karen Knudsen
  • Non-Executive Director
  • --
  • Diana Layfield
  • Non-Executive Director
  • 135.00K
  • Anna Olive Magdelene Manz
  • Non-Executive Director
  • 140.00K
  • Marcus Wallenberg
  • Non-Executive Director
  • 155.00K
  • Dr. Euan Ashley
  • Non-Executive Director
  • 160.00K
  • Philip A J Broadley
  • Non-Executive Director,Senior Independent Director
  • 233.00K
  • Adrian C N Kemp
  • Company Secretary
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More